| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/2005 | US20050010035 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 01/13/2005 | US20050010034 Pyrogenic exotoxin type C (SPE-C) protein for use in generating vaccine for use in prevention of streptocccal infection/poisioning |
| 01/13/2005 | US20050010033 Pyrogenic exotoxin type C (SPE-C) protein for use in generating vaccine for use in prevention of streptocccal infection/poisioning |
| 01/13/2005 | US20050010032 Vaccine for periodontal disease |
| 01/13/2005 | US20050010031 2-(S)-{3-(S)-allyl-4-[2-(R)-amino-3-(4-fluorophenyl)propionyl]-2-oxo-piperazin-1-yl}-N-methyl-3-naphthalen-2-yl-propionamide for example; various diseases and disorders including controlling appetite and treating diabetes |
| 01/13/2005 | US20050010030 Nucleotide sequences comprising lymphocyte receptor for use in generating immunoglobulin which suppress or prevent activation or proliferation of v-beta response; immunotherapy and treatment of joint inflammation |
| 01/13/2005 | US20050009752 Novel peptides and medicinal uses thereof |
| 01/13/2005 | US20050009750 Fibroblast growth factor receptors and methods for their use |
| 01/13/2005 | US20050009749 Also a gene encoding the protein and a Streptomyces sp. strain producing it; used to treat neurodegenerative disorders like Alzheimer's disease and Down syndrome |
| 01/13/2005 | US20050009745 TSG101 as inhibitor of HIV production |
| 01/13/2005 | US20050009743 Analyzing changes in protein; genetic engineering |
| 01/13/2005 | US20050009739 Formulation strategies in stabilizing peptides in organic solvents and in dried states |
| 01/13/2005 | US20050009205 Fluorescently labeled G protein coupled receptor ligand comprising motilin for use in monitoring, identifying and screening drugs which modulate or treat cell proliferative disorders |
| 01/13/2005 | US20050009187 Environmental stress-responsive promoter and genes encoding transcriptional factor |
| 01/13/2005 | US20050009186 Expression vector comprising 3' and 5' long terminal repeats and preferential splice junctions for use as heterologous gene transfer tool; gene therapy |
| 01/13/2005 | US20050009169 Silent information regulator protein (SIR4) for use as tool identifying agent which prolong life and stability of eukaryotic cells |
| 01/13/2005 | US20050009152 Expression vector comprising nucleotide sequences coding protein associated with lysine biosynthetic pathway for transfecting cells and fermentive production of lysine for use in cosmetics, medicines and animal feeds |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009149 Trimeric tumor necrosis factor receptors for use as modulator for treatment of rheumatoid arthritis, atherosclerosis, osteoporosis, allograft rejection, cancer, inflammatory bowel and autoimmune diseases |
| 01/13/2005 | US20050009148 Preparing recombinant, preferentially glycosylated antihemophilic factor for use in treating blood disorders and hemophilia |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009145 Mammalian receptor proteins; related reagents and methods |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009142 52906, 33408, and 12189, novel potassium channel family members and uses thereof |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009138 Expression vector comprising nucleotide sequences coding interleukin-1 receptor protein for use in diagnosis and treatment of infection, inflammation, arthritis and diabetes |
| 01/13/2005 | US20050009137 Intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/13/2005 | US20050009127 Using glucagon like peptide binding activity as diagnostic tool in detecting modulator of impaired glucose tolerance |
| 01/13/2005 | US20050009108 Using 16s ribosomal RNA as diagnostic tool in detection of campylobacter DNA sequences in biological fluids; diagnosing bacterial infection |
| 01/13/2005 | US20050009107 Using hybridoma cells to generate monoclonal antibody specific to 7-transmembrane receptor protein for use in the diagnosis, prevention and treatment of psychological and nervous system disorders |
| 01/13/2005 | US20050009106 Mammalian cytokine; related reagents |
| 01/13/2005 | US20050009104 Methods of attaching soluble HLA to solid supports |
| 01/13/2005 | US20050009103 Methods of precise molecular-level determination of ligand-receptor interactions and designing selective drug compounds based on said interactions |
| 01/13/2005 | US20050009096 Using myelin/oligodendrocyte glycoprotein (MOG) as diagnostic tool in detecting, classifying, evaluating and monitoring allergic encephalomyelitis (EAE) and autoimmune diseases in mammals |
| 01/13/2005 | US20050009089 Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter protein ABC1 |
| 01/13/2005 | US20050009086 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009075 IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides |
| 01/13/2005 | US20050009073 Polyamide nucleic acid derivatives, and agents, and processes for preparing them |
| 01/13/2005 | US20050009061 Anther-specific genes, their promoters, and uses of the same |
| 01/13/2005 | US20050009041 Peptide nucleic acids and synthetic procedures therefor |
| 01/13/2005 | US20050009040 Using probes/primers of mutant microsatellite nucleotide sequence to diagnose/prognose cell proliferative disorders of lung, head and neck |
| 01/13/2005 | US20050009029 Expression system |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050009023 Using allelic variance in genes associated with neuroadaptation of stress-responsive systems as a diagnostic and prognostic indicators of addiction reward disorders |
| 01/13/2005 | US20050009019 Engineered microbial yeast comprising nucleotide sequence encoding kinase or phosphatase that modulates phosphorylation; useful in screening therapeutic agents for Alzheimer's disease |
| 01/13/2005 | US20050009012 Genome comprising polynucleotide encoding promoter linked to a transcription unit encoding a fusion protein; autoproteolytic peptide |
| 01/13/2005 | US20050009008 Functional influenza virus-like particles (VLPs) |
| 01/13/2005 | US20050008659 Prevention, therapy of Eimeria infections; induction resistance to coccidiosis |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008653 In situ binding of polypeptide to stabilizer; induction apoptosis |
| 01/13/2005 | US20050008651 Modulating replication via immunogen and pharmaceutically or veterinarily acceptable vehicles |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008649 Endostatin fused to antibody as antitumor agents; stability |
| 01/13/2005 | US20050008645 Antibodies Specific For Phosphatase Subunit of LAR |
| 01/13/2005 | US20050008644 Potentiation of the immune response |
| 01/13/2005 | US20050008638 Anticancer agents; immunomoderator; cytokine, antagonist thereof |
| 01/13/2005 | US20050008636 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 01/13/2005 | US20050008634 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus |
| 01/13/2005 | US20050008627 Administering tumor necrosis factor directly to lungs; asthma therapy; chronic obstructive pulmonary disease |
| 01/13/2005 | US20050008616 Multiple sclerosis therapy; selective oxidation of interferon polypeptide |
| 01/13/2005 | US20050008615 Conjugates comprising human IL-18 and substitution mutants thereof |
| 01/13/2005 | US20050008611 Agent for the prevention and treatment of sexually transmitted diseases-I |
| 01/13/2005 | US20050008602 Oligopeptides for promoting hair growth |
| 01/13/2005 | US20050008573 Diagnosis of tumors; in vivo imaging |
| 01/13/2005 | US20050006807 Obtaining protein mixture; incubating with crosslinking agent; molding; hardening; removal from mold |
| 01/13/2005 | DE102004013715A1 Detecting contamination, e.g. of foodstuffs such as meat, by brain and bone marrow tissue components, comprises extracting CNS-specific indicator protein using hydrophobic solvent and detecting by e.g. mass spectrometry |
| 01/13/2005 | CA2568859A1 Cytokine variant polypeptides |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531240A1 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | CA2531238A1 Polypeptides having binding affinity for her2 |
| 01/13/2005 | CA2531226A1 Ubiquitinated tnf receptor 2 and its uses |
| 01/13/2005 | CA2530866A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | CA2530530A1 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | CA2530393A1 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | CA2529917A1 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/13/2005 | CA2529578A1 Antibodies for use in increasing bone mineralization |
| 01/13/2005 | CA2529555A1 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | CA2529058A1 Increased t-cell tumor infiltration by mutant light |
| 01/13/2005 | CA2528964A1 Interferon variants with improved properties |
| 01/13/2005 | CA2527908A1 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | CA2527905A1 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | CA2524148A1 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | CA2522329A1 Inhibitors of coronavirus |
| 01/13/2005 | CA2513213A1 Albumin fusion proteins |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496122A1 Novel meloidogyne-resistance gene and utilization thereof |
| 01/12/2005 | EP1496116A1 Anticancer agents using vero toxin variants |
| 01/12/2005 | EP1496065A2 Breast specific genes and proteins |
| 01/12/2005 | EP1495672A1 Functional plant, promoter to be used for producing the functional plant and method of using the same |
| 01/12/2005 | EP1495330A1 Method of identifying transmembrane protein-interacting compounds |
| 01/12/2005 | EP1495322A2 Heteroclitic analogs and related methods |
| 01/12/2005 | EP1495142A1 "doping" in walk-through mutagenesis |
| 01/12/2005 | EP1495128A1 Ehanced protein expression in bacillus |
| 01/12/2005 | EP1495124A2 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1495054A2 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |